Trial Evaluating an Investigational Agent for Management of Transitional Cell Carcinoma

ETHOS VETERINARY HEALTH CONTRACT RESEARCH STUDY

DESCRIPTION

This trial is designed to evaluate the safety and preliminary pain management and anti-cancer effectiveness of a novel therapy in dogs with bladder transitional cell carcinoma (TCC). The trial involves one-time procedure administered directly into the bladder using a urinary catheter.

ELIGIBILITY CRITERIA

• Dogs with a diagnosis of TCC exclusively associated with the bladder (metastasis is acceptable).
• Accompanying urinary tract symptoms associated with bladder cancer.

• Bladder lesion does not prevent the passage of urinary catheter.

PARTICIPATING HOSPITALS

• The Oncology Service – Richmond, VA

Interested?

Enroll or request more information below